Opus Point Partners Management, LLC historic quarter change: USA Stocks, Reduced
In share positions in stocks (listed in the US), over 7 quarters from 2014-12-31 to 2016-09-30, Opus Point Partners Management, LLC opened 19 positions, added to 60, reduced 54 and sold out of 17.
- Q3 2016: Stock ILMN; Country of operation United States; Class COM; Shares before 18,741.
- Q3 2016: Stock INCY; Country of operation United States; Class COM; Shares before 35,237.
- Q3 2016: Stock ALKS; Country of operation —; Class SHS; Shares before 82,858.
- Q3 2016: Stock AMGN; Country of operation United States; Class COM; Shares before 18,619.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1600175), 7 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-18). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2014-12-31.
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q3 2016 | ILMN
ILLUMINA INC | United States | COM | 18,741 | 18,400 | -341 | $2,631,000 | $3,343,000 | +$712,000 | 2016-11-14 |
|---|
| Q3 2016 | INCY
INCYTE CORP | United States | COM | 35,237 | 34,626 | -611 | $2,818,000 | $3,265,000 | +$447,000 | 2016-11-14 |
|---|
| Q3 2016 | ALKS
ALKERMES PLC | | SHS | 82,858 | 81,677 | -1,181 | $3,581,000 | $3,841,000 | +$260,000 | 2016-11-14 |
|---|
| Q3 2016 | AMGN
AMGEN INC | United States | COM | 18,619 | 18,322 | -297 | $2,833,000 | $3,056,000 | +$223,000 | 2016-11-14 |
|---|
| Q3 2016 | UTHR
UNITED THERAPEUTICS CORP DEL | United States | COM | 2,064 | 1,768 | -296 | $219,000 | $209,000 | -$10,000 | 2016-11-14 |
|---|
| Q2 2016 | ALNY
ALNYLAM PHARMACEUTICALS INC | United States | COM | 77,593 | 43,684 | -33,909 | $4,871,000 | $2,424,000 | -$2,447,000 | 2016-08-15 |
|---|
| Q2 2016 | IONS
IONIS PHARMACEUTICALS INC | United States | COM | 96,808 | 70,868 | -25,940 | $3,921,000 | $1,651,000 | -$2,270,000 | 2016-08-15 |
|---|
| Q2 2016 | BMRN
BIOMARIN PHARMACEUTICAL INC | United States | COM | 48,260 | 28,915 | -19,345 | $3,980,000 | $2,250,000 | -$1,730,000 | 2016-08-15 |
|---|
| Q2 2016 | AMGN
AMGEN INC | United States | COM | 27,184 | 18,619 | -8,565 | $4,076,000 | $2,833,000 | -$1,243,000 | 2016-08-15 |
|---|
| Q2 2016 | INCY
INCYTE CORP | United States | COM | 51,677 | 35,237 | -16,440 | $3,745,000 | $2,818,000 | -$927,000 | 2016-08-15 |
|---|
| Q2 2016 | ILMN
ILLUMINA INC | United States | COM | 21,729 | 18,741 | -2,988 | $3,522,000 | $2,631,000 | -$891,000 | 2016-08-15 |
|---|
| Q2 2016 | HOLX
HOLOGIC INC | United States | COM | 38,700 | 16,500 | -22,200 | $1,335,000 | $571,000 | -$764,000 | 2016-08-15 |
|---|
| Q2 2016 | BIIB
BIOGEN INC | United States | COM | 11,125 | 9,042 | -2,083 | $2,896,000 | $2,187,000 | -$709,000 | 2016-08-15 |
|---|
| Q2 2016 | REGN
REGENERON PHARMACEUTICALS | United States | COM | 8,929 | 7,233 | -1,696 | $3,218,000 | $2,526,000 | -$692,000 | 2016-08-15 |
|---|
| Q2 2016 | VRTX
VERTEX PHARMACEUTICALS INC | United States | COM | 41,137 | 30,248 | -10,889 | $3,270,000 | $2,602,000 | -$668,000 | 2016-08-15 |
|---|
| Q2 2016 | MTD
METTLER TOLEDO INTERNATIONAL | | COM | 9,500 | 7,188 | -2,312 | $3,275,000 | $2,623,000 | -$652,000 | 2016-08-15 |
|---|
| Q2 2016 | RARE
ULTRAGENYX PHARMACEUTICAL IN | United States | COM | 13,500 | 7,074 | -6,426 | $855,000 | $346,000 | -$509,000 | 2016-08-15 |
|---|
| Q2 2016 | BMY
BRISTOL MYERS SQUIBB CO | United States | COM | 77,100 | 71,703 | -5,397 | $4,925,000 | $5,274,000 | +$349,000 | 2016-08-15 |
|---|
| Q2 2016 | AGIO
AGIOS PHARMACEUTICALS INC | United States | COM | 51,000 | 43,295 | -7,705 | $2,071,000 | $1,814,000 | -$257,000 | 2016-08-15 |
|---|
| Q2 2016 | UTHR
UNITED THERAPEUTICS CORP DEL | United States | COM | 3,848 | 2,064 | -1,784 | $429,000 | $219,000 | -$210,000 | 2016-08-15 |
|---|
| Q2 2016 | ALKS
ALKERMES PLC | | SHS | 102,277 | 82,858 | -19,419 | $3,497,000 | $3,581,000 | +$84,000 | 2016-08-15 |
|---|
| Q2 2016 | MRK
MERCK & CO INC | United States | COM | 90,000 | 83,700 | -6,300 | $4,762,000 | $4,822,000 | +$60,000 | 2016-08-15 |
|---|
| Q1 2016 | GILD
GILEAD SCIENCES INC | United States | COM | 33,700 | 3,282 | -30,418 | $3,410,000 | $301,000 | -$3,109,000 | 2016-05-16 |
|---|
| Q1 2016 | REGN
REGENERON PHARMACEUTICALS | United States | COM | 10,714 | 8,929 | -1,785 | $5,816,000 | $3,218,000 | -$2,598,000 | 2016-05-16 |
|---|
| Q1 2016 | IONS
IONIS PHARMACEUTICALS INC | United States | COM | 102,459 | 96,808 | -5,651 | $6,345,000 | $3,921,000 | -$2,424,000 | 2016-05-16 |
|---|
| Q1 2016 | VRTX
VERTEX PHARMACEUTICALS INC | United States | COM | 41,662 | 41,137 | -525 | $5,242,000 | $3,270,000 | -$1,972,000 | 2016-05-16 |
|---|
| Q1 2016 | AMGN
AMGEN INC | United States | COM | 35,773 | 27,184 | -8,589 | $5,807,000 | $4,076,000 | -$1,731,000 | 2016-05-16 |
|---|
| Q1 2016 | VCEL
VERICEL CORP | United States | COM | 332,157 | 298,941 | -33,216 | $857,000 | $1,752,000 | +$895,000 | 2016-05-16 |
|---|
| Q1 2016 | ILMN
ILLUMINA INC | United States | COM | 22,643 | 21,729 | -914 | $4,346,000 | $3,522,000 | -$824,000 | 2016-05-16 |
|---|
| Q1 2016 | UTHR
UNITED THERAPEUTICS CORP DEL | United States | COM | 6,514 | 3,848 | -2,666 | $1,020,000 | $429,000 | -$591,000 | 2016-05-16 |
|---|
| Q1 2016 | HOLX
HOLOGIC INC | United States | COM | 48,000 | 38,700 | -9,300 | $1,857,000 | $1,335,000 | -$522,000 | 2016-05-16 |
|---|
| Q1 2016 | LAB
FLUIDIGM CORP DEL | United States | COM | 70,000 | 45,000 | -25,000 | $757,000 | $363,000 | -$394,000 | 2016-05-16 |
|---|
| Q1 2016 | MTD
METTLER TOLEDO INTERNATIONAL | | COM | 9,700 | 9,500 | -200 | $3,290,000 | $3,275,000 | -$15,000 | 2016-05-16 |
|---|
| Q4 2015 | BIIB
BIOGEN INC | United States | COM | 17,467 | 10,482 | -6,985 | $5,097,000 | $3,211,000 | -$1,886,000 | 2016-02-16 |
|---|
| Q4 2015 | AGIO
AGIOS PHARMACEUTICALS INC | United States | COM | 46,000 | 34,000 | -12,000 | $3,247,000 | $2,207,000 | -$1,040,000 | 2016-02-16 |
|---|
| Q4 2015 | MTD
METTLER TOLEDO INTERNATIONAL | | COM | 15,200 | 9,700 | -5,500 | $4,328,000 | $3,290,000 | -$1,038,000 | 2016-02-16 |
|---|
| Q4 2015 | ILMN
ILLUMINA INC | United States | COM | 28,334 | 22,643 | -5,691 | $4,982,000 | $4,346,000 | -$636,000 | 2016-02-16 |
|---|
| Q4 2015 | PCRX
PACIRA PHARMACEUTICALS INC | United States | COM | 21,000 | 19,110 | -1,890 | $863,000 | $1,467,000 | +$604,000 | 2016-02-16 |
|---|
| Q4 2015 | INFIQ
INFINITY PHARMACEUTICALS INC | United States | COM | 45,300 | 30,000 | -15,300 | $383,000 | $236,000 | -$147,000 | 2016-02-16 |
|---|
| Q3 2015 | PCRX
PACIRA PHARMACEUTICALS INC | United States | COM | 47,000 | 21,000 | -26,000 | $3,324,000 | $863,000 | -$2,461,000 | 2015-11-16 |
|---|
| Q3 2015 | INFIQ
INFINITY PHARMACEUTICALS INC | United States | COM | 80,000 | 45,300 | -34,700 | $876,000 | $383,000 | -$493,000 | 2015-11-16 |
|---|
| Q3 2015 | VCEL
VERICEL CORP | United States | COM | 362,157 | 332,157 | -30,000 | $1,293,000 | $900,000 | -$393,000 | 2015-11-16 |
|---|
| Q2 2015 | INCY
INCYTE CORPORATION CMN | United States | COM | 43,682 | 41,873 | -1,809 | $4,004,000 | $4,364,000 | +$360,000 | 2015-08-14 |
|---|
| Q2 2015 | ALNY
ALNYLAM PHARMACEUTICALS, INC. CMN | United States | COM | 37,388 | 34,979 | -2,409 | $3,904,000 | $4,193,000 | +$289,000 | 2015-08-14 |
|---|
| Q2 2015 | RARE
ULTRAGENYX PHARMACEUTICAL INC. CMN | United States | COM | 12,000 | 9,000 | -3,000 | $745,000 | $922,000 | +$177,000 | 2015-08-14 |
|---|
| Q2 2015 | HOLX
HOLOGIC INCORPORATED CMN | United States | COM | 50,000 | 48,000 | -2,000 | $1,651,000 | $1,827,000 | +$176,000 | 2015-08-14 |
|---|
| Q1 2015 | AMGN
AMGEN INC. CMN | United States | COM | 17,046 | 4,938 | -12,108 | $2,715,000 | $789,000 | -$1,926,000 | 2015-05-18 |
|---|
| Q1 2015 | UTHR
UNITED THERAPEUTICS CORP CMN | United States | COM | 19,054 | 5,213 | -13,841 | $2,468,000 | $899,000 | -$1,569,000 | 2015-05-18 |
|---|
| Q1 2015 | BIIB
BIOGEN INC. CMN | United States | COM | 9,486 | 9,331 | -155 | $3,221,000 | $3,940,000 | +$719,000 | 2015-05-18 |
|---|
| Q1 2015 | INCY
INCYTE CORPORATION CMN | United States | COM | 60,877 | 43,682 | -17,195 | $4,450,000 | $4,004,000 | -$446,000 | 2015-05-18 |
|---|
| Q1 2015 | HOLX
HOLOGIC INCORPORATED CMN | United States | COM | 53,000 | 50,000 | -3,000 | $1,417,000 | $1,651,000 | +$234,000 | 2015-05-18 |
|---|
| Q1 2015 | BMRN
BIOMARIN PHARMACEUTICAL INC CMN | United States | COM | 43,731 | 32,545 | -11,186 | $3,953,000 | $4,056,000 | +$103,000 | 2015-05-18 |
|---|
| Q1 2015 | MTD
METTLER-TOLEDO INTL CMN | | COM | 10,000 | 9,436 | -564 | $3,025,000 | $3,101,000 | +$76,000 | 2015-05-18 |
|---|
| Q1 2015 | GILD
GILEAD SCIENCES CMN | United States | COM | 4,328 | 3,651 | -677 | $408,000 | $358,000 | -$50,000 | 2015-05-18 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |